Atlas Trials

Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration

Clinical trial NCT04984707 · COMPLETED

Trial details

NCT number
NCT04984707
Sponsor
Suzhou Kintor Pharmaceutical Inc,
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Androgenetic Alopecia
Start date
2019-01-28
Primary completion
2019-04-11
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.